PAX8 and rhabdoid tumor: In summary, PAX8 inhibition-resistant ccRCC cells display a global reduction in the kidney-specific cis-regulatory and transcriptional programs in favor of a dedifferentiated state which shares molecular features of SMARCB1 loss in pediatric rhabdoid tumors.